-
IMPORTANT: In the next few weeks, we will be upgrading the message board software. We expect minimal downtime during the upgrade, and we will attempt to complete this during low-traffic hours. We will post an exact time several days ahead of the switch.Dismiss Notice
In preparation for the upgrade, we will be performing board maintenance, such as moving boards to Lost Civilizations where appropriate. Lost Civilizations is a category for companies that have either been dissolved or acquired. The boards serve as both an archive of the old company posts, as well as a place for former employees to reminisce or reconnect, as they will remain open for posting. We may also remove some board threads that have been inactive for several years.
Recent Posts
-
Multaq Sucks
Did sanofi pull their GLP-1? And they spent 12 billion on not bringing out Accomplia, a weight loss agent. They just burn stockholder $$$ and the stock stays in same range.
-
Phathom
I don't know of one rep that is happy at this dumpster fire. #phuckedupcompany
-
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
via The company’s monoclonal antibody met primary and secondary endpoints as a maintenance therapy for ulcerative colitis in a Phase III trial. article source
-
Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal
via Eli Lilly is continuing to ride the radiopharma wave, paying Aktis Oncology $60 million upfront to work on therapeutic and diagnostic products against multiple targets. Lilly established itself as a player in the nascent radiopharma space by...
-
FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
via The U.S. Food and Drug Administration's staff reviewers on Tuesday raised concerns that Guardant Health's (GH.O) experimental blood test for a cancer of colon or rectum may fail to detect some types of tumors that can later become cancerous....
-
Pheon rides wave of ADC interest with $120M financing
via British biotechnology startup Pheon Therapeutics has raised another $120 million in venture funding, riding a wave of investor interest in the type of cancer medicines, known as antibody-drug conjugates, it specializes in. article source
-
3 up-and-coming US biotech hotspots
via For decades, a handful of regions around Boston, San Francisco and New York dominated the U.S. pharma and biotech scene. But they’re not the only players in the life sciences game. article source
- + Show More
-
General Discussion
Discussion boards of general interest for those in the pharma, biotech, medical device, and related industries
-
Pharma/Biotech Companies
Anonymous discussion boards for pharmaceutical and biotech companies
-
Regional Discussion and Job Opportunities
Discussion and job opportunities by region
-
Lost Civilizations
Anonymous discussion boards for pharma/medical companies that no longer exist due to acquisition or other factors
-
Laboratory/Diagnostic Sales
Anonymous discussion boards for lab sales/diagnostics companies
-
Animal Health Sales
Anonymous discussion boards for animal health companies
-
Medical Equipment/Device Sales
Anonymous discussion boards for medical equipment/device companies
-
Pharmacies
Anonymous boards for pharmacy employees
-
PBMs
Anonymous discussion boards for PBMs
-
Pharma/Healthcare Marketing Agencies
Anonymous discussion boards for pharma/healthcare marketing agencies
-
Dental Reps
Anonymous discussion boards for dental health companies
-
Managed Care Specialists
Anonymous discussion boards for managed care specialists
-
Pharma IT
Anonymous discussion boards for pharma IT employees